Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct;35(10):1117-1125.
doi: 10.1007/s12149-021-01647-y. Epub 2021 Jun 25.

Investigation of perfusion defects by Q-SPECT/CT in patients with mild-to-moderate course of COVID-19 and low clinical probability for pulmonary embolism

Affiliations

Investigation of perfusion defects by Q-SPECT/CT in patients with mild-to-moderate course of COVID-19 and low clinical probability for pulmonary embolism

Buket Caliskaner Ozturk et al. Ann Nucl Med. 2021 Oct.

Erratum in

Abstract

Objective: Pulmonary embolism is a severe source of mortality and morbidity in patients with severe and critical coronavirus disease 2019. It is not yet clear whether the tendency to thrombosis is increased in the mild-to-moderate course of COVID-19. Our research aims to show the clinical benefit of Q-SPECT/CT in diagnosing PD in outpatients treated with mild-to-moderate course of COVID-19 and to determine the frequency of perfusion defects in these patients having relatively lower risk.

Methods: All patients who underwent Q-SPECT/CT with suspicion of embolism were examined retrospectively. Only patients with low clinical probability and mild-to-moderate course of COVID-19 for PE were included in the study. The patients were evaluated comparatively as those with and without perfusion defects. Patients were divided into laboratory suspicion, clinical suspicion, or clinical and laboratory suspicion.

Results: In outpatients with mild-to-moderate COVID-19 with low clinical probability for PE, PD without CT abnormality was detected with a rate of 36.6% with Q-SPECT/CT performed for complaints of high D-dimer and/or dyspnea. None of the patients had PD at more proximal level than the segment level. PD with no concomitant CT abnormality was observed with a rate of 56.5% in patients with both clinical and laboratory suspicion. For D-dimer = 0.5 mg/dL cut-off sensitivity is 85%, for D-dimer = 1.5 mg/dL cut-off specificity 81%.

Conclusion: Thrombosis tendency is also present in outpatients with mild-to-moderate COVID-19, and these patients should also be offered anticoagulant prophylaxis during the COVID-19 period.

Keywords: COVID-19; Pandemic; Perfusion defects; Pulmonary embolism; Q-SPECT/CT.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
A sample Q-SPECT/CT images-1. Image 1: Perfusion defect with segmental wedge-style in the superior segment of the lower lobe of the right lung, incompatible with CT
Fig. 2
Fig. 2
A sample Q-SPECT/CT images-2. Image 2: Multiple peripherally located subsegmental perfusion defects in bilateral lung parenchyma areas, incompatible with CT
Fig. 3
Fig. 3
A sample Q-SPECT/CT images-3. Image 3: Segmentary perfusion defect in the upper lobe anterior segment of the left lung, incompatible with CT
Fig. 4
Fig. 4
d-dimer ROC curve. The test result variable (s): Q-SPECT/CT, d-dimer, has at least one tie between the positive actual and negative actual state groups. The smallest cut-off value is the minimum observed test value minus 1, and the most considerable cut-off value is the maximum observed test value plus 1. All the other cut-off values are the averages of two consecutive ordered observed test values

Comment in

Similar articles

Cited by

References

    1. Grillet F, Behr J, Calame P, Aubry S, Delabrousse E. Acute pulmonary embolism associated with COVID-19 pneumonia detected with pulmonary CT angiography. Radiology. Radiology Radiol Soc N Am. 2020;296:E186–E188. doi: 10.1148/radiol.2020201544. - DOI - PMC - PubMed
    1. Lodigiani C, Iapichino G, Carenzo L, Cecconi M, Ferrazzi P, Sebastian T, et al. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Thromb Res. 2020;191:9–14. doi: 10.1016/j.thromres.2020.04.024. - DOI - PMC - PubMed
    1. Klok FA, Kruip MJHA, van der Meer NJM, Arbous MS, Gommers DAMPJ, Kant KM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020;191:145–147. doi: 10.1016/j.thromres.2020.04.013. - DOI - PMC - PubMed
    1. Guideline C. Diagnosis and treatment protocol for novel coronavirus pneumonia (Trial version 7) Chin Med J (Engl) 2020;133:1087–1095. doi: 10.1097/CM9.0000000000000819. - DOI - PMC - PubMed
    1. Gervaise A, Bouzad C, Peroux E, Helissey C. Acute pulmonary embolism in non-hospitalized COVID-19 patients referred to CTPA by emergency department. Eur Radiol Eur Radiol. 2020;30:6170–6177. doi: 10.1007/s00330-020-06977-5. - DOI - PMC - PubMed

MeSH terms

Substances